FindTrial
Sign In

Effects of vitamin D supplementation on brain structure and function in patients with major depressive disorder

Base on multimodal MRI to investigate the role of vitamin D in the development of major depression disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054570
Enrollment
Unknown
Registered
2021-12-20
Start date
2017-10-26
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

major depressive disorder

Interventions

Experimental group:vitamin D + antidepressant medications
Control group:antidepressants

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for depression; 2. Aged 18 to 65 years; 3. Right-handed.

Exclusion criteria

Exclusion criteria: 1. The presence of other mental disorders, such as substance-induced mood disorders, bipolar disorder, anxiety disorders, schizophrenia, substance abuse or dependence; 2. History of major physical or neurological diseases; 3. A history of head injury with loss of consciousness; 4. MRI contraindications such as pregnancy.

Design outcomes

Primary

MeasureTime frame
magnetic resonance imaging;vitamin D level;—

Countries

China

Contacts

Public ContactYu Yongqiang

The First Affiliated Hospital of Anhui Medical University

cjr.yuyongqiang@vip.163.com+86 55162923537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026